SummaryRMgm-5245
|
||||||||
*RMgm-5245| Successful modification | The parasite was generated by the genetic modification |
| The mutant contains the following genetic modification(s) | Gene tagging |
| Reference (PubMed-PMID number) |
Reference 1 (PMID number) : 36040030 |
| MR4 number | |
| top of page | |
| Parent parasite used to introduce the genetic modification | |
| Rodent Malaria Parasite | P. berghei |
| Parent strain/line | P. berghei ANKA |
| Name parent line/clone | P. berghei ANKA 2.34 |
| Other information parent line | P. berghei ANKA 2.34 is a cloned, gametocyte producer line of the ANKA strain (PubMed: PMID: 15137943). |
| top of page | |
| The mutant parasite was generated by | |
| Name PI/Researcher | Ambekar, SV, Mair GR |
| Name Group/Department | Biomedical Sciences, |
| Name Institute | Iowa State University |
| City | Ames |
| Country | USA |
| top of page | |
| Name of the mutant parasite | |
| RMgm number | RMgm-5245 |
| Principal name | Nup434::GFP |
| Alternative name | |
| Standardized name | |
| Is the mutant parasite cloned after genetic modification | Yes |
| top of page | |
| Phenotype | |
| Asexual blood stage | The protein localized to the nuclear periphery typical for FG-repeat nucleoporins in P. berghei |
| Gametocyte/Gamete | Not tested |
| Fertilization and ookinete | Not tested |
| Oocyst | Not tested |
| Sporozoite | Not tested |
| Liver stage | Not tested |
| Additional remarks phenotype | Mutant/mutation Protein (function) and Phenotype Additional information Other mutants
|
Tagged: Mutant parasite with a tagged gene| top of page | |||||||||||||||||||||||||||
| Details of the target gene | |||||||||||||||||||||||||||
| Gene Model of Rodent Parasite | PBANKA_0309400 | ||||||||||||||||||||||||||
| Gene Model P. falciparum ortholog | PF3D7_0212500 | ||||||||||||||||||||||||||
| Gene product | conserved Plasmodium protein, unknown function | ||||||||||||||||||||||||||
| Gene product: Alternative name | NUP434 | ||||||||||||||||||||||||||
| top of page | |||||||||||||||||||||||||||
| Details of the genetic modification | |||||||||||||||||||||||||||
| Name of the tag | GFP | ||||||||||||||||||||||||||
| Details of tagging | C-terminal | ||||||||||||||||||||||||||
| Additional remarks: tagging | |||||||||||||||||||||||||||
| Commercial source of tag-antibodies | |||||||||||||||||||||||||||
| Type of plasmid/construct | (Linear) plasmid single cross-over | ||||||||||||||||||||||||||
| PlasmoGEM (Sanger) construct/vector used | No | ||||||||||||||||||||||||||
| Modified PlasmoGEM construct/vector used | No | ||||||||||||||||||||||||||
| Plasmid/construct map | |||||||||||||||||||||||||||
| Plasmid/construct sequence | |||||||||||||||||||||||||||
| Restriction sites to linearize plasmid | |||||||||||||||||||||||||||
| Selectable marker used to select the mutant parasite | tgdhfr | ||||||||||||||||||||||||||
| Promoter of the selectable marker | eef1a | ||||||||||||||||||||||||||
| Selection (positive) procedure | pyrimethamine | ||||||||||||||||||||||||||
| Selection (negative) procedure | No | ||||||||||||||||||||||||||
| Additional remarks genetic modification | For comparison of various biotin ligases, nucleoporin 138 (Nup138) was used as the bait protein. The C-terminal region of the gene was PCR-amplified from P. berghei genomic DNA using Q5 High-Fidelity DNA polymerase. BioID2-3XHA was obtained from Addgene (#74224) and was fused in-frame to the C-terminal end of the Nup138 resulting in plasmid pLIS0574 which also contains the Toxoplasma gondii DHFR selection marker. Each Nup138 tagging construct includes a 1,848 bp fragment encoding the C-terminal region of the 3,714 bp long gene to promote homologous recombination. Similarly, another fusion protein plasmid was made with the same bait protein but with a 13X GGGGS linker between the C-terminus of the protein and BioID2. TurboID-3XHA (Addgene #107171) was fused in-frame to the C-terminal end of the Nup138 using the plasmid pLIS0574; likewise mini-TurboID-3XHA (Addgene #107172) and BirA* (12). As a wild-type control, we used the 2.34 P. berghei clone containing none of the biotin ligases. To ensure that the nuclear periphery-specific signal was from the biotin ligase fused to Nup138, we constructed a plasmid with the promoter sequence of Nup138 and TurboID as a negative control. All cloning was carried out either with T4 DNA ligase or NEBuilder HiFi (NEB). To tag all additional FG-Nups with TurboID, we replaced the Nup138 flank in pLIS0654 with flanks for the respective genes by amplifying the C-terminal regions from the genomic locus. For visualization of candidate-Nups identified via mass spectrometry, we used pLIS0010 to tag each protein with GFP. For nup434::turboID-ha, we replaced the gene flank using pLIS0654. | ||||||||||||||||||||||||||
| Additional remarks selection procedure | |||||||||||||||||||||||||||
| |||||||||||||||||||||||||||
| top of page | |||||||||||||||||||||||||||